Gaucher's disease type I

4 total trials MedDRA PT

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

A Multicenter, Long-term, Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral … Recruitment ended

2024-511172-33-00 9 2024-05-10 "Gaucher Disease Type 1"
A dose finding study of LY3884961 in patients with Gaucher disease Halted

2022-500281-10-02 9 2026-02-06 "Type 1 Gaucher Disease (Peripheral/Non-neuronopathic Manifes"
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Ended

2024-510751-34-00 5 2019-03-26 "Gaucher's disease type I; Gaucher's disease type III"
Venglustat in Combination with Cerezyme in Adult Patients with Gaucher Disease Type 3 with venglustat monotherapy extension Ended

2023-508646-18-00 4 2017-09-18 "Gaucher disease type 3"

Showing 1–4 of 4 trials